サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1412755

L-アルギニン市場：タイプ別、用途別-2024-2030年の世界予測

L-Arginine Market by Type (Food Grade, Pharma Grade), Application (Pharmaceuticals, Supplements & Nutrition) - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 195 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
L-アルギニン市場：タイプ別、用途別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 195 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

L-アルギニン市場規模は2023年に5億9,145万米ドルと推定され、2024年には6億3,832万米ドルに達し、CAGR 7.15%で2030年には9億5,960万米ドルに達すると予測されます。

L-アルギニンの世界市場

主な市場の統計
基準年[2023］ 5億9,145万米ドル
予測年[2024] 6億3,832万米ドル
予測年 [2030] 9億5,960万米ドル
CAGR（%） 7.15%
L-アルギニン Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスはL-アルギニン市場を評価する上で極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、L-アルギニン市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-L-アルギニン市場の市場規模および予測は？

2-L-アルギニン市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-L-アルギニン市場における技術動向と規制の枠組みは？

4-L-アルギニン市場における主要ベンダーの市場シェアは？

5-L-アルギニン市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 血管および心臓関連の健康問題の蔓延
      • さまざまな病気の治療のためのアジュバントとしてのアルギニンに関する研究が増加
      • 炎症や片頭痛の治療に使用が増加
    • 抑制要因
      • 製品の価格が高い,
    • 機会
      • 化粧品開発での活用拡大
      • 新薬開発への投資
    • 課題
      • アルギニン医薬品包装の製品リコール
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 L-アルギニン市場：タイプ別

  • 食品等級
  • 製薬グレード

第7章 L-アルギニン市場：用途別

  • 医薬品
  • サプリメントと栄養

第8章 南北アメリカのL-アルギニン市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域のL-アルギニン市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカのL-アルギニン市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第12章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Ajinomoto Co., Inc.
    • CJ CheilJedang Corporation
    • Daesang Corporation
    • Glanbia Plc
    • Jarrow Formulas, Inc.
    • Jing Jing Pharmaceutical Co., Ltd.
    • Kyowa Hakko Bio Co., Ltd.
    • NOW Health Group, Inc.
    • Olympian Labs, Inc.
    • Prinova Group LLC
    • Twinlab Consolidation Corporation
  • 主要な製品ポートフォリオ

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. L-ARGININE MARKET RESEARCH PROCESS
  • FIGURE 2. L-ARGININE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. L-ARGININE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. L-ARGININE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. L-ARGININE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. L-ARGININE MARKET DYNAMICS
  • FIGURE 7. L-ARGININE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. L-ARGININE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. L-ARGININE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. L-ARGININE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS L-ARGININE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS L-ARGININE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES L-ARGININE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES L-ARGININE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC L-ARGININE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC L-ARGININE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA L-ARGININE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA L-ARGININE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. L-ARGININE MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 20. L-ARGININE MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. L-ARGININE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. L-ARGININE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL L-ARGININE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. L-ARGININE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. L-ARGININE MARKET SIZE, BY FOOD GRADE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. L-ARGININE MARKET SIZE, BY PHARMA GRADE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. L-ARGININE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 9. L-ARGININE MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. L-ARGININE MARKET SIZE, BY SUPPLEMENTS & NUTRITION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. AMERICAS L-ARGININE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. AMERICAS L-ARGININE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS L-ARGININE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 14. ARGENTINA L-ARGININE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. ARGENTINA L-ARGININE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. BRAZIL L-ARGININE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. BRAZIL L-ARGININE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. CANADA L-ARGININE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. CANADA L-ARGININE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. MEXICO L-ARGININE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. MEXICO L-ARGININE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. UNITED STATES L-ARGININE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. UNITED STATES L-ARGININE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES L-ARGININE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 25. ASIA-PACIFIC L-ARGININE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. ASIA-PACIFIC L-ARGININE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC L-ARGININE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. AUSTRALIA L-ARGININE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. AUSTRALIA L-ARGININE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. CHINA L-ARGININE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. CHINA L-ARGININE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. INDIA L-ARGININE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. INDIA L-ARGININE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. INDONESIA L-ARGININE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. INDONESIA L-ARGININE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. JAPAN L-ARGININE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. JAPAN L-ARGININE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. MALAYSIA L-ARGININE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. MALAYSIA L-ARGININE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. PHILIPPINES L-ARGININE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. PHILIPPINES L-ARGININE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. SINGAPORE L-ARGININE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. SINGAPORE L-ARGININE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. SOUTH KOREA L-ARGININE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. SOUTH KOREA L-ARGININE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. TAIWAN L-ARGININE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. TAIWAN L-ARGININE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. THAILAND L-ARGININE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. THAILAND L-ARGININE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. VIETNAM L-ARGININE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. VIETNAM L-ARGININE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. EUROPE, MIDDLE EAST & AFRICA L-ARGININE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. EUROPE, MIDDLE EAST & AFRICA L-ARGININE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA L-ARGININE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. DENMARK L-ARGININE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. DENMARK L-ARGININE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. EGYPT L-ARGININE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. EGYPT L-ARGININE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. FINLAND L-ARGININE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. FINLAND L-ARGININE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. FRANCE L-ARGININE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. FRANCE L-ARGININE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. GERMANY L-ARGININE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. GERMANY L-ARGININE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. ISRAEL L-ARGININE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. ISRAEL L-ARGININE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. ITALY L-ARGININE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ITALY L-ARGININE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. NETHERLANDS L-ARGININE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. NETHERLANDS L-ARGININE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. NIGERIA L-ARGININE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. NIGERIA L-ARGININE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. NORWAY L-ARGININE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NORWAY L-ARGININE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. POLAND L-ARGININE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. POLAND L-ARGININE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. QATAR L-ARGININE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. QATAR L-ARGININE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. RUSSIA L-ARGININE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. RUSSIA L-ARGININE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. SAUDI ARABIA L-ARGININE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. SAUDI ARABIA L-ARGININE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH AFRICA L-ARGININE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH AFRICA L-ARGININE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SPAIN L-ARGININE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SPAIN L-ARGININE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SWEDEN L-ARGININE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SWEDEN L-ARGININE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SWITZERLAND L-ARGININE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SWITZERLAND L-ARGININE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. TURKEY L-ARGININE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. TURKEY L-ARGININE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED ARAB EMIRATES L-ARGININE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED ARAB EMIRATES L-ARGININE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED KINGDOM L-ARGININE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED KINGDOM L-ARGININE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. L-ARGININE MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 98. L-ARGININE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 99. L-ARGININE MARKET LICENSE & PRICING
目次
Product Code: MRR-742BD5180307

[195 Pages Report] The L-Arginine Market size was estimated at USD 591.45 million in 2023 and expected to reach USD 638.32 million in 2024, at a CAGR 7.15% to reach USD 959.60 million by 2030.

Global L-Arginine Market

KEY MARKET STATISTICS
Base Year [2023] USD 591.45 million
Estimated Year [2024] USD 638.32 million
Forecast Year [2030] USD 959.60 million
CAGR (%) 7.15%
L-Arginine Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the L-Arginine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the L-Arginine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the L-Arginine Market, highlighting leading vendors and their innovative profiles. These include Ajinomoto Co., Inc., CJ CheilJedang Corporation, Daesang Corporation, Glanbia Plc, Jarrow Formulas, Inc., Jing Jing Pharmaceutical Co., Ltd., Kyowa Hakko Bio Co., Ltd., NOW Health Group, Inc., Olympian Labs, Inc., Prinova Group LLC, and Twinlab Consolidation Corporation.

Market Segmentation & Coverage

This research report categorizes the L-Arginine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Food Grade
    • Pharma Grade
  • Application
    • Pharmaceuticals
    • Supplements & Nutrition
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the L-Arginine Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the L-Arginine Market?

3. What are the technology trends and regulatory frameworks in the L-Arginine Market?

4. What is the market share of the leading vendors in the L-Arginine Market?

5. Which modes and strategic moves are suitable for entering the L-Arginine Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. L-Arginine Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of blood vessels and heart-related health problems
      • 5.1.1.2. Increasing researches on arginine as an adjuvant for the treatment of various diseases
      • 5.1.1.3. Growing use to cure inflammation and migraine
    • 5.1.2. Restraints
      • 5.1.2.1. high price of the product,
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing utilization in cosmetic products development
      • 5.1.3.2. Investment for novel drug development
    • 5.1.4. Challenges
      • 5.1.4.1. Product recalls for arginine drug packaging
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. L-Arginine Market, by Type

  • 6.1. Introduction
  • 6.2. Food Grade
  • 6.3. Pharma Grade

7. L-Arginine Market, by Application

  • 7.1. Introduction
  • 7.2. Pharmaceuticals
  • 7.3. Supplements & Nutrition

8. Americas L-Arginine Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific L-Arginine Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa L-Arginine Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. Ajinomoto Co., Inc.
    • 12.1.2. CJ CheilJedang Corporation
    • 12.1.3. Daesang Corporation
    • 12.1.4. Glanbia Plc
    • 12.1.5. Jarrow Formulas, Inc.
    • 12.1.6. Jing Jing Pharmaceutical Co., Ltd.
    • 12.1.7. Kyowa Hakko Bio Co., Ltd.
    • 12.1.8. NOW Health Group, Inc.
    • 12.1.9. Olympian Labs, Inc.
    • 12.1.10. Prinova Group LLC
    • 12.1.11. Twinlab Consolidation Corporation
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing